GigaIO Introduces the First Ever 32 GPU Single-Node Supercomputer for Generative AI and Accelerated Computing

Genedata Announces Partnership with Dragonfly Therapeutics to Support Novel Immune Engager R&D

Genedata Biologics supports R&D processes at innovative biopharmaceutical company developing breakthrough immunotherapies for the treatment of cancer and chronic inflammatory diseases

Phastar's B Corp™ certification affirms its status as a 'force for good' organization

Phastar's B Corp™ certification affirms its status as a 'force for good' organization International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices.

Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements

Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements Cary, North Carolina- July 11th, 2023: Skyelarke, a health tech company, has announced some significant new additions to SkyePay, a cutting-edge patient payment technology built by and for the clinical research industry.

NCC Group Welcomes New Chief Technology Officer, Siân John

NCC Group, one of the world’s largest security consultancies with over 35 global offices, 2,000 employees in 12 countries and 14,000 clients, today appointed Siân John as Chief Technology Officer. Joining from Microsoft and with 25 years of cybersecurity experience across strategy, business risk, privacy, and technology, Siân will drive innovation, insights and intelligence at the firm through close interaction with clients, industry, and academia.

Cotiviti Introduces Prepay Claim Review Solution for Coordination of Benefits (COB) Validation

New addition to comprehensive COB suite enables health plans to improve claim accuracy while reducing provider and member abrasion

JPA Health Unveils GRETEL Trails: Revolutionizing Integrated Healthcare Marketing with AI-Powered Insight Engine and Chatbot

Pharma Targeting Launch ‘Partner Identifier’ to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients

Pharma Targeting, part of the The Targeting Group and a leading global pharmaceutical market intelligence and data company, has unveiled its latest pioneering initiative, designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. The service uses data-driven intelligence to help customers identify and engage with the right partner, whether it be for licencing, in-licensing, funding, distribution, or any other business need.

LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR MIRIKIZUMAB (OMVOH ®▼) FOR THE TREATMENT OF ELIGIBLE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS.1

Mirikizumab is the first IL-23p19 targeted biologic to demonstrate efficacy for induction and maintenance therapy of moderately to severely active Ulcerative Colitis. Marketing authorisation was based on two randomised, double-blind, placebo-controlled phase 3 trials, LUCENT-1 and LUCENT-2. In both studies mirikizumab achieved primary and key secondary endpoints, including sustained clinical remission1 Decreases in bowel urgency severity were observed as early as week 2 in patients treated with mirikizumab versus placebo in LUCENT-11

Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test

Cleveland Diagnostics has expanded to open a new facility to support the growing, nationwide demand for its prostate cancer test: IsoPSA. The new facility will be critical as the company continues to grow and develop additional tests for different types of cancers.

Volume and Cost of Clinical Lab Tests Expected to Rise in 2023, Report Finds

Volume and Cost of Clinical Lab Tests Expected to Rise in 2023, Report Finds: Variety and complexity of routine and genetic testing poses challenge for health plans and clinicians

Pharma Targeting launches FMCG Targeting

Pharma Targeting launches FMCG Targeting Exclusive offer for FMCG service providers increases requests for proposals and helps clients be first to market.

Rhapsody Takes Top Spot for EMPI in Recent Black Book Ranking Over 900 Hospitals and Inpatient Organizations and 4,000 Physician Practices Participated in 2023 Financial and RCM Solution Survey

Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for HEDIS® Measurement Year 2023

Achievement marks 23rd consecutive year that Cotiviti’s quality measures have passed NCQA’s intensive validation process

DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico

DNAnexus today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.

Light Chain Bioscience Chooses Genedata to Digitalize Cell Line & Bioprocess Development

Off-the-shelf workflow platform accelerates development of manufacturing processes for innovative biotherapeutics

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Flywheel, the leading medical imaging data and AI platform, announces it has raised $54 million in Series D funding.

NCC Group Appoints New Chief Operating Officer, Kevin Brown

NCC Group, one of the world’s largest security consultancies with over 35 global offices, 2,000 employees and 14,000 clients, has appointed Kevin Brown as Chief Operating Officer.

OMAPiX Announces Strategic Partnerships with Leading Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development

OMAPiX announces strategic collaborations with Vizgen, Resolve Biosciences, and Ultivue as part of its ongoing commitment to expand its services portfolio in Europe and North America.

Persist AI Adopts Scispot to operate as a Digital Biotech company

Persist AI leverages Scispot's advanced tech stack to automate research workflows and scale AI capabilities, accelerating drug formulation development